Lorie Marchitto

638 total citations
17 papers, 135 citations indexed

About

Lorie Marchitto is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, Lorie Marchitto has authored 17 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Infectious Diseases and 8 papers in Virology. Recurrent topics in Lorie Marchitto's work include HIV Research and Treatment (8 papers), Immune Cell Function and Interaction (8 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Lorie Marchitto is often cited by papers focused on HIV Research and Treatment (8 papers), Immune Cell Function and Interaction (8 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Lorie Marchitto collaborates with scholars based in Canada, United States and Germany. Lorie Marchitto's co-authors include Andrés Finzi, Jonathan Richard, Guillaume Goyette, Daniel E. Kaufmann, Isabel Fernández, Benoît Trottier, Claude Fortin, Madéleine Durand, Aissa Benyoucef and Fabien Touzot and has published in prestigious journals such as Journal of Virology, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Lorie Marchitto

16 papers receiving 134 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lorie Marchitto Canada	7	73	45	40	25	18	17	135
Narayanaiah Cheedarla United States	7	71 1.0×	43 1.0×	88 2.2×	33 1.3×	14 0.8×	19	175
Federica Bergami Italy	9	142 1.9×	28 0.6×	16 0.4×	23 0.9×	4 0.2×	16	186
Paola Martinez-Murillo United States	7	101 1.4×	94 2.1×	75 1.9×	52 2.1×	6 0.3×	11	215
Amanda Eaton United States	6	29 0.4×	32 0.7×	45 1.1×	28 1.1×	12 0.7×	9	102
Laura Thümmler Germany	8	254 3.5×	52 1.2×	8 0.2×	26 1.0×	8 0.4×	16	293
Marco Vecchia Italy	6	181 2.5×	107 2.4×	10 0.3×	39 1.6×	8 0.4×	17	290
Hedvig Glans Sweden	8	82 1.1×	46 1.0×	17 0.4×	31 1.2×	3 0.2×	13	177
Anneth Tumbo Tanzania	4	74 1.0×	46 1.0×	12 0.3×	15 0.6×	14 0.8×	5	142
Chengzi I. Kaku United States	7	230 3.2×	93 2.1×	7 0.2×	52 2.1×	11 0.6×	9	276
Marloes Grobben Netherlands	8	66 0.9×	47 1.0×	37 0.9×	21 0.8×	2 0.1×	18	135

Countries citing papers authored by Lorie Marchitto

Since Specialization

Citations

This map shows the geographic impact of Lorie Marchitto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorie Marchitto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorie Marchitto more than expected).

Fields of papers citing papers by Lorie Marchitto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorie Marchitto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorie Marchitto. The network helps show where Lorie Marchitto may publish in the future.

Co-authorship network of co-authors of Lorie Marchitto

This figure shows the co-authorship network connecting the top 25 collaborators of Lorie Marchitto. A scholar is included among the top collaborators of Lorie Marchitto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorie Marchitto. Lorie Marchitto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Richard, Jonathan, Gérémy Sannier, Jérémie Prévost, et al.. (2024). CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies. mBio. 15(11). e0182724–e0182724. 2 indexed citations

Lamarche, Caroline, Karthik Tennankore, Lorie Marchitto, et al.. (2024). Impact of Prolonged SARS-CoV-2 Dosing Interval in Hemodialysis Patients. Kidney International Reports. 9(8). 2575–2577.

Tauzin, Alexandra, Lorie Marchitto, Mehdi Benlarbi, et al.. (2024). Three families of CD4-induced antibodies are associated with the capacity of plasma from people living with HIV to mediate ADCC in the presence of CD4-mimetics. Journal of Virology. 98(10). e0096024–e0096024. 4 indexed citations

Marchitto, Lorie, Alexandra Tauzin, Mehdi Benlarbi, et al.. (2024). NTB-A and 2B4 Natural Killer Cell Receptors Modulate the Capacity of a Cocktail of Non-Neutralizing Antibodies and a Small CD4-Mimetic to Eliminate HIV-1-Infected Cells by Antibody-Dependent Cellular Cytotoxicity. Viruses. 16(7). 1167–1167. 1 indexed citations

Benyoucef, Aissa, Émilie Heckel, Lorie Marchitto, et al.. (2023). NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome. Journal of Allergy and Clinical Immunology. 157(3). 711–721.e5. 7 indexed citations

Ding, Shilei, William D. Tolbert, Lorie Marchitto, et al.. (2023). Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC. Viruses. 15(5). 1185–1185. 7 indexed citations

Laumaea, Annemarie, Lorie Marchitto, Shilei Ding, et al.. (2023). Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity. Cell Reports. 42(1). 111983–111983. 11 indexed citations

Marchitto, Lorie, Debashree Chatterjee, Shilei Ding, et al.. (2023). Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV. Viruses. 15(10). 2004–2004. 4 indexed citations

Ding, Shilei, Kevin Sung, Vrasha Chohan, et al.. (2023). Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother. iScience. 26(5). 106762–106762. 1 indexed citations

10.

Marchitto, Lorie, Mehdi Benlarbi, Jérémie Prévost, et al.. (2023). Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity. mBio. 14(4). e0078923–e0078923. 7 indexed citations

11.

Gong, Shang Yu, Shilei Ding, Mehdi Benlarbi, et al.. (2022). Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2. Viruses. 14(10). 2178–2178. 9 indexed citations

12.

Marchitto, Lorie, Guillaume Goyette, Daniel E. Kaufmann, et al.. (2022). Innate Immunity and SARS-CoV-2 Vaccine Response in Hemodialysis Patients. Kidney360. 3(10). 1763–1768. 2 indexed citations

13.

Marchitto, Lorie, Guillaume Goyette, Claude Fortin, et al.. (2022). Covid-19 vaccine immunogenicity in people living with HIV-1. Vaccine. 40(26). 3633–3637. 45 indexed citations

14.

Boutin, Marianne, Dani Vézina, Shilei Ding, et al.. (2022). Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies. mBio. 13(3). e0057722–e0057722. 5 indexed citations

15.

Laumaea, Annemarie, Antoine Lewin, Debashree Chatterjee, et al.. (2022). COVID‐19 vaccine humoral response in frequent platelet donors with plateletpheresis‐associated lymphopenia. Transfusion. 62(9). 1779–1790. 2 indexed citations

16.

Fernández, Isabel, Lorie Marchitto, Marie‐Paule Morin, et al.. (2021). Multicentric Castleman disease revealing complete signal transducer and activator of transcription 1 deficiency treated by JAK1/2 inhibition. The Journal of Allergy and Clinical Immunology In Practice. 9(10). 3838–3840.e1. 1 indexed citations

17.

Barsalou, Julie, Annaliesse Blincoe, Isabel Fernández, et al.. (2018). Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome. Frontiers in Immunology. 9. 2162–2162. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact